feed,title,long_url,short_url
MarketWatch,Biogen’s pivotal moment: Will the FDA approve the experimental — and controversial — Alzheimer’s disease drug aducanumab?,http://www.marketwatch.com/news/story.asp?guid=%7B20C05575-04D4-B545-7473-DF19E8D0803F%7D&siteid=rss&rss=1,https://on.mktw.net/34FulM3
